
Daniel Bui
Examiner (ID: 8414, Phone: (571)272-2618 , Office: P/2912 )
| Most Active Art Unit | 2912 |
| Art Unit(s) | 2912 |
| Total Applications | 4278 |
| Issued Applications | 4257 |
| Pending Applications | 0 |
| Abandoned Applications | 21 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16562742
[patent_doc_number] => 10888087
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Lactam solubility
[patent_app_type] => utility
[patent_app_number] => 15/750906
[patent_app_country] => US
[patent_app_date] => 2016-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2648
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15750906
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/750906 | Lactam solubility | Jul 27, 2016 | Issued |
Array
(
[id] => 13675059
[patent_doc_number] => 20160376263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/219573
[patent_app_country] => US
[patent_app_date] => 2016-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 97873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15219573
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/219573 | BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF | Jul 25, 2016 | Abandoned |
Array
(
[id] => 11393858
[patent_doc_number] => 20170014393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL'
[patent_app_type] => utility
[patent_app_number] => 15/209862
[patent_app_country] => US
[patent_app_date] => 2016-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15541
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15209862
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/209862 | METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL | Jul 13, 2016 | Abandoned |
Array
(
[id] => 11364022
[patent_doc_number] => 20170002004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'ADO-RESISTANT CYSTEAMINE ANALOGS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/201969
[patent_app_country] => US
[patent_app_date] => 2016-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14065
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15201969
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/201969 | ADO-resistant cysteamine analogs and uses thereof | Jul 4, 2016 | Issued |
Array
(
[id] => 11350184
[patent_doc_number] => 20160368924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'PURINONE COMPOUNDS AS KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/200834
[patent_app_country] => US
[patent_app_date] => 2016-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 103878
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15200834
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/200834 | PURINONE COMPOUNDS AS KINASE INHIBITORS | Jun 30, 2016 | Abandoned |
Array
(
[id] => 11834596
[patent_doc_number] => 20170216315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'USES OF ERGOSTATRIEN-3beta-OL'
[patent_app_type] => utility
[patent_app_number] => 15/199065
[patent_app_country] => US
[patent_app_date] => 2016-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13725
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15199065
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/199065 | USES OF ERGOSTATRIEN-3beta-OL | Jun 29, 2016 | Abandoned |
Array
(
[id] => 11099503
[patent_doc_number] => 20160296473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'FORMULATIONS OF 6-MERCAPTOPURINE'
[patent_app_type] => utility
[patent_app_number] => 15/185204
[patent_app_country] => US
[patent_app_date] => 2016-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13185
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15185204
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/185204 | Formulations of 6-mercaptopurine | Jun 16, 2016 | Issued |
Array
(
[id] => 11348753
[patent_doc_number] => 20160367493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'METHOD AND IMPROVED PHARMACEUTICAL COMPOSITION FOR ENHANCING TRANSDERMAL DELIVERY OF PDE-5 INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 15/184667
[patent_app_country] => US
[patent_app_date] => 2016-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4620
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15184667
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/184667 | METHOD AND IMPROVED PHARMACEUTICAL COMPOSITION FOR ENHANCING TRANSDERMAL DELIVERY OF PDE-5 INHIBITOR | Jun 15, 2016 | Abandoned |
Array
(
[id] => 14143087
[patent_doc_number] => 10251895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-09
[patent_title] => Topical compositions and methods for treating psoriasis
[patent_app_type] => utility
[patent_app_number] => 15/173961
[patent_app_country] => US
[patent_app_date] => 2016-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8871
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15173961
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/173961 | Topical compositions and methods for treating psoriasis | Jun 5, 2016 | Issued |
Array
(
[id] => 11074171
[patent_doc_number] => 20160271134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'Modulators of Androgen Synthesis'
[patent_app_type] => utility
[patent_app_number] => 15/169610
[patent_app_country] => US
[patent_app_date] => 2016-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 36398
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15169610
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/169610 | Modulators of androgen synthesis | May 30, 2016 | Issued |
Array
(
[id] => 17349970
[patent_doc_number] => 11224588
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-18
[patent_title] => Combination of lipoic acid and taurine as osmoprotective agent
[patent_app_type] => utility
[patent_app_number] => 15/575187
[patent_app_country] => US
[patent_app_date] => 2016-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 4485
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15575187
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/575187 | Combination of lipoic acid and taurine as osmoprotective agent | May 19, 2016 | Issued |
Array
(
[id] => 17843735
[patent_doc_number] => 11433077
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-06
[patent_title] => Calcineurin inhibitors of the setron family for the treatment of hearing loss
[patent_app_type] => utility
[patent_app_number] => 15/574547
[patent_app_country] => US
[patent_app_date] => 2016-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 10654
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15574547
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/574547 | Calcineurin inhibitors of the setron family for the treatment of hearing loss | May 17, 2016 | Issued |
Array
(
[id] => 14594057
[patent_doc_number] => 10350203
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-16
[patent_title] => Multidrug infusion for pain control
[patent_app_type] => utility
[patent_app_number] => 15/157716
[patent_app_country] => US
[patent_app_date] => 2016-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6173
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15157716
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/157716 | Multidrug infusion for pain control | May 17, 2016 | Issued |
Array
(
[id] => 11059478
[patent_doc_number] => 20160256440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'MULTISUBSTITUTED AROMATIC COMPOUNDS AS INHIBITORS OF THROMBIN'
[patent_app_type] => utility
[patent_app_number] => 15/155954
[patent_app_country] => US
[patent_app_date] => 2016-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51386
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15155954
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/155954 | MULTISUBSTITUTED AROMATIC COMPOUNDS AS INHIBITORS OF THROMBIN | May 15, 2016 | Abandoned |
| 15/143867 | METHODS OF REDUCING RISK OF PRETERM BIRTH | May 1, 2016 | Abandoned |
Array
(
[id] => 12656824
[patent_doc_number] => 20180110774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF PULMONARY HYPERTENSION
[patent_app_type] => utility
[patent_app_number] => 15/570042
[patent_app_country] => US
[patent_app_date] => 2016-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570042
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/570042 | COMPOSITIONS AND METHODS FOR TREATMENT OF PULMONARY HYPERTENSION | Apr 27, 2016 | Abandoned |
Array
(
[id] => 12656842
[patent_doc_number] => 20180110780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => AGENT FOR ALLEVIATING SIDE EFFECT OF ANTITUMOR DRUG
[patent_app_type] => utility
[patent_app_number] => 15/570048
[patent_app_country] => US
[patent_app_date] => 2016-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7256
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570048
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/570048 | AGENT FOR ALLEVIATING SIDE EFFECT OF ANTITUMOR DRUG | Apr 27, 2016 | Abandoned |
Array
(
[id] => 11023586
[patent_doc_number] => 20160220540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/098955
[patent_app_country] => US
[patent_app_date] => 2016-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 103383
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15098955
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/098955 | COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES | Apr 13, 2016 | Abandoned |
Array
(
[id] => 12238375
[patent_doc_number] => 20180071238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'Compositions and Methods for Traumatized Tissues Using Zinc Chelators'
[patent_app_type] => utility
[patent_app_number] => 15/561632
[patent_app_country] => US
[patent_app_date] => 2016-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6940
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15561632
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/561632 | Compositions and Methods for Traumatized Tissues Using Zinc Chelators | Apr 7, 2016 | Abandoned |
Array
(
[id] => 11090638
[patent_doc_number] => 20160287607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'NON-RETINOID ANTAGONISTS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND STARGARDT DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/093179
[patent_app_country] => US
[patent_app_date] => 2016-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 10025
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15093179
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/093179 | NON-RETINOID ANTAGONISTS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND STARGARDT DISEASE | Apr 6, 2016 | Abandoned |